Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :2005641
Publication Date : //

Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards.


Resistance to the nitrogen mustards in patients with chronic lymphocytic leukemia (CLL) correlates with an enhanced removal of melphalan-induced DNA interstrand cross-links. This finding suggests that DNA repair enzymes may be involved in this process. The activity of 3-methyladenine-DNA glycosylase, which can release altered bases, including adducts at the N-7 position of guanine, was increased significantly in lymphocytes from patients with resistant CLL compared with those from untreated CLL patients. Since glycosylase activity varies with cell proliferation, the amount of [3H]thymidine incorporated into DNA was determined and found to be elevated almost threefold in lymphocytes from patients with resistant CLL. The ratio of glycosylase activity to level of thymidine incorporation did not differ between these two groups of patients. Northern blot analysis of ERCC1 gene (a putative DNA repair enzyme involved in nucleotide excision repair) expression in lymphocytes from patients with CLL revealed multiple gene transcripts (1.1, 3.4, and 3.8 kilobases). In addition, analysis of two samples revealed the presence of a 2.6-kilobase transcript. The 2.6-kilobase transcript was recognized by specific RNA probes that hybridize to antisense ERCC1 transcripts. Levels of expression of the 1.1-kilobase protein encoding transcript in lymphocytes from patients with resistant CLL were increased twofold to threefold above those of untreated patients with CLL. These results indicate that increased expression of ERCC1 and increased activity of 3-methyladenine-DNA glycosylase occur with the development of resistance to the nitrogen mustards in patients with CLL, suggesting a role for enhanced DNA repair in this process.

Authors : Geleziunas R , McQuillan A , Malapetsa A , Hutchinson M , Kopriva D , Wainberg M A , Hiscott J , Bramson J , Panasci L ,

Related products :

Catalog number Product name Quantity
31-062 DOK1 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr 0.05 mg
31-076 DOK2 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr 0.05 mg
T18-009-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
E7671h Human Chronic Lymphocytic Leukemia Up Regulated Pr 96T
T18-010-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) tissue 0.1 mg
T18-011-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) tissue 0.1 mg
T18-009-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) tissue 0.1 mg
CLMN CLLU1 Gene chronic lymphocytic leukemia up-regulated 1
CSB-EL005562HU Human Chronic lymphocytic leukemia up-regulated protein 1(CLLU1) ELISA kit 96T
CLN3 CLLU1OS Gene chronic lymphocytic leukemia up-regulated 1 opposite strand
CSB-EL005562HU Human Chronic lymphocytic leukemia up-regulated protein 1(CLLU1) ELISA kit SpeciesHuman 96T
EIAAB07928 Chronic lymphocytic leukemia up-regulated protein 1,CLLU1,Homo sapiens,Human
CLLU1_HUMAN ELISA Kit FOR Chronic lymphocytic leukemia up-regulated protein 1; organism: Human; gene name: CLLU1 96T
orb61239 Dasatinib Dasatinib is an oral multi- BCR_ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML) after imatinib treatment and Philadelphia ch 100 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur